Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology (Breast cancers, Lung Cancer and Others), Central Nervous System, Hematology, Respiratory, Immunology, and Others)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027

  • Published On : Sep 2019 |
  • Pages : 170 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Precision Medicine Market – Insights

Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. Precision medicine has gained popularity due to positive results obtained by precision medicine in treating cancer. It allows doctors and researchers to predict more accurate treatment and preventive strategies for any particular disease. Precision medicine is also known as personalized medicine or individualized medicine, which target the mutations of normal body cells into cancerous cells. The use of precision medicine in targeted treatment, specifically in cancer has lesser side effects with quick recovery as compared to conventional drugs.

Furthermore, improvement in FDA oversees of drugs tests and other technologies support the innovation in precision medicine by ensuring that they are safe and effective. The advancements in genetic sequencing also supports precision medicine, as it is completely dependent on genetic sequencing.

The global precision medicine market was valued at US$ 61,447.3 million in 2018 and is expected to witness a robust CAGR of 10.1% during the forecast period (2019-2027).

Global Precision Medicine Market Share (%) Analysis, By Product Type, 2018

Precision Medicine  | Coherent Market Insights

Source: Coherent Market Insights (2019)

Increasing Development of Big Data Analysis and IT Sector are expected to Drive Growth of the Precision Medicine Market

The cost and time required for developing new precision medicines is expected to reduce due to the increasing development of big data analysis and IT sector. The development of new precision medicines will help in providing the right prescription to improve patient’s health. Huge amount of useful data required for tailored prescription is created by numerous genetic tests and diagnostic tests, which are to be carried out to provide precision medicines. Physicians are able to provide precision medicine, as big data analysis and IT are able to crunch, analyze, and store the necessary data. Key players in the market who are working towards developing bioinformatics technology for precision medicine research applications are funded by the government. For instance, in August 2017, Armonica Technologies, Inc., an Albuquerque-based company, received US$ 1.5 million as a catalyst fund (funds for a startup business).

Precision Medicine Market – Restraints

Factors restraining growth of the precision medicine market include unavailability of insurance coverage on genetic test, which is a mandatory test to analyze the mutation, to prescribe precision medicines accordingly and high cost of genetic test. For instance, according to the U.S. National Library of Medicine data published in September 2019, the cost of genetic testing can range from US$ 100 to above US$ 2,000, depending on the nature and complexity of the test. The cost increases if more than one test is necessary or if multiple family members must be tested to obtain a meaningful result.

Precision Medicine Market – Regional Insights

On the basis of region, the global precision medicine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounts for largest share in the global precision medicine market, followed by Europe. This is mainly attributed to increasing awareness and initiatives related to precision medicine in North America. In 2015, President Obama announced the launch of Precision Medicine Initiative that aimed to revolutionize the way of treatment to improve health, as precision medicine provides an innovative approach that studies the unique gene sequences of individual and offers tailored treatment.

Precision Medicine Initiative has led to powerful novel discoveries and several advanced treatments, which are tailored for specific characteristics such as genetic makeup or genetic profile of an individual tumor that helps the doctor to determine the treatment procedure. This is expected to drive growth of the precision medicine market in the near future. The Precision Medicine Initiative invested US$ 215 million in the National Institutes of Health in fiscal 2016 budget, which is expected to accelerate biomedical research by providing advanced tools and innovative therapies to the physicians, which are tailored according to individual need, and in turn, is expected to fuel growth of the precision medicine market in the near future.

Global Precision Medicine Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Precision Medicine  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Precision Medicine Market - Competitive Landscape

Some of the major players operating in the precision medicine market includes Intomics, Ferrer Incode, Nanostring Technologies, Inc., Tepnel Pharma Services, Pfizer, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.

Precision Medicine Initiative aims to use advanced technologies in clinical and basic research to develop therapeutics that selectively target and kill cancer cells. This allow researchers to develop chemically tractable probes that can image cancer in vivo environment. As, this medicine is one of the emerging technology used to treat children or adolescent patients suffering from brain tumor that have no other effective therapies, various companies are continuously investing in research and development to further refine precision medicines for interventional surgical imaging as well as for diagnostic and therapeutic applications also. For instance, in 2015, Pfizer, Inc. established Center of Excellence in Precision Medicine (CEPM) in Chile, in partnership with Thermo Fisher Scientific, to validate new, more precise, and less invasive technologies for diagnosing cancer.

Furthermore, less cost of treatment attract patients towards precision medicine, as precision medicine reduces most of the expensive treatments cost, which are not required since genetic testing helps the oncologists to diagnose the disease easily. Due to this, precision medicine is expected to be more effective in treating oncology-related diseases, cardiovascular diseases, psychiatric disorders, neurodegenerative diseases, arthritis, obesity, diabetes, pain, and Alzheimer’s disease

Market Dynamics

The two recent FDA drug approvals for Kalydeco (ivacaftor) and Keytruda (pembrolizumab) pertaining to 33 cystic fibrosis mutations and cancer treatment based on a genetic feature respectively, is expected to exhibit growth in the precision medicine market. For example, The National Cancer Institute (NCI) plans to support new immunotherapy clinical trials, antibody, testing of new combinations of the cell, small molecule, and radiation therapy studies, which include sequencing of tumor specimens.

NCI conducted NCI-COG Pediatric MATCH trial in July 2017, enrolling children and adolescent who are receiving advanced cancer therapy based on their genetic abnormality. In the same time, NCI launched various precision medicine trials, which include Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST), Lung Cancer Master Protocol (Lung-MAP), Molecular Analysis for Therapy Choice (NCI-MATCH), and Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT). This initiative are expected to increase the demand for precision medicines in the near future.

 Key features of the study:

  • This report provides an in-depth analysis of precision medicine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019 – 2027), considering 2018 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, product pipeline, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global precision medicine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
  • Key companies covered as a part of this study include Novartis AG, Intomics, Ferrer Incode, Nanostring Technologies, Inc., Tepnel Pharma Services, Pfizer, Inc., Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The global precision medicine market report caters to various stakeholders in this industry including investors, manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Global Precision Medicine Market, By Technology:
    • Bioinformatics
    • Gene Sequencing
    • Drug Discovery
    • Precision Molecular Diagnostics
    • Big Data Analytics
  • Global Precision Medicine Market, By Application:
    • Oncology
      • Breast cancers
      • Lung Cancer
      • Others
    • Central Nervous System
    • Hematology
    • Respiratory
    • Immunology
    • Others
  • Global Precision Medicine Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
    • Middle East
      • By Country:
        • GCC Countries
        • Israel
        • Rest of Middle East
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Technology:
        • Bioinformatics
        • Gene Sequencing
        • Drug Discovery
        • Precision Molecular Diagnostics
        • Big Data Analytics
      • By Application:
        • Oncology
          • Breast cancers
          • Lung Cancer
          • Others
        • Central Nervous System
        • Hematology
        • Respiratory
        • Immunology
        • Others
  • Company Profiles
    • Novartis AG*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Intomics
    • Ferrer Incode
    • Nanostring Technologies, Inc.
    • Tepnel Pharma Services
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co. Inc.
    • Qiagen N.V.
    • Quest Diagnostics

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Value Chain
    • PEST Analysis
  4. Global Precision Medicine Market, By Technology, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Bioinformatics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Gene Sequencing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Drug Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Precision Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Big Data Analytics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  5. Global Precision Medicine Market, By Application, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
        • Breast cancers
        • Lung Cancer
        • Others
    • Central Nervous System
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Immunology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Million)
  6. Global Precision Medicine Market, By Region, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2019 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Technology, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2019 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2019 – 2027, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Company Profiles
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Intomics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Ferrer Incode
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nanostring Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Tepnel Pharma Services
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Qiagen N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Quest Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 29 figures on "Precision Medicine Market - Global Forecast to 2027”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.